These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Organ interactions in the hepatorenal syndrome. Neuschwander-Tetri BA New Horiz; 1994 Nov; 2(4):527-44. PubMed ID: 7804802 [TBL] [Abstract][Full Text] [Related]
44. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Packer M Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129 [TBL] [Abstract][Full Text] [Related]
45. Effect of renal prostaglandins on survival in patients with liver cirrhosis. Kawasaki H; Nosaka Y; Yamada S; Uemasu J; Hirayama C; Suyama A Am J Gastroenterol; 1989 Mar; 84(3):285-9. PubMed ID: 2919584 [TBL] [Abstract][Full Text] [Related]
46. Pathogenesis of ascites in cirrhosis and portal hypertension. Heneghan MA; Harrison PM Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415 [TBL] [Abstract][Full Text] [Related]
47. Prostaglandins, renin and atrial natriuretic peptide in the control of the circulation and renal function in heart failure in the dog. Riegger GA; Elsner D; Hildenbrand J; Koch K; Kromer EP Prog Clin Biol Res; 1989; 301():455-8. PubMed ID: 2529553 [No Abstract] [Full Text] [Related]
48. [Functional insufficiency in chronic liver disease patients. The hepatorenal syndrome]. Gentilini P; Laffi G Minerva Med; 1987 May; 78(10):651-4. PubMed ID: 3587710 [No Abstract] [Full Text] [Related]
49. Hepatic nephropathy, related to haemodynamics. Ring-Larsen H Liver; 1983 Oct; 3(5):265-89. PubMed ID: 6358759 [No Abstract] [Full Text] [Related]
51. The role of prostaglandins in arterial hypertension: a critical review. Groene HJ; Dunn MJ Adv Nephrol Necker Hosp; 1985; 14():241-72. PubMed ID: 3919534 [No Abstract] [Full Text] [Related]
52. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914 [TBL] [Abstract][Full Text] [Related]
53. Renal hemodynamics and the renin-angiotensin system in cirrhosis. Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770 [TBL] [Abstract][Full Text] [Related]
54. The hepatorenal syndrome. Papper S Clin Nephrol; 1975 Aug; 4(2):41-4. PubMed ID: 1098816 [No Abstract] [Full Text] [Related]
55. [Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology]. Thomsen AC Ugeskr Laeger; 1968 Apr; 130(14):585-91. PubMed ID: 4303382 [No Abstract] [Full Text] [Related]
56. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437 [TBL] [Abstract][Full Text] [Related]
57. [Antihypertensive therapy in renal failure]. Mayer G Acta Med Austriaca; 1995; 22(3):51-3. PubMed ID: 8571752 [TBL] [Abstract][Full Text] [Related]